0001209191-16-110142.txt : 20160323 0001209191-16-110142.hdr.sgml : 20160323 20160323090226 ACCESSION NUMBER: 0001209191-16-110142 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160321 FILED AS OF DATE: 20160323 DATE AS OF CHANGE: 20160323 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: OXIGENE INC CENTRAL INDEX KEY: 0000908259 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 133679168 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 701 GATEWAY BLVD. CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 650-635-7000 MAIL ADDRESS: STREET 1: 701 GATEWAY BLVD. CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Schwieterman William D CENTRAL INDEX KEY: 0001403961 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-21990 FILM NUMBER: 161522597 MAIL ADDRESS: STREET 1: C/O OXIGENE, INC., 230 THIRD AVENUE CITY: WALTHAM STATE: MA ZIP: 02451 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2016-03-21 0 0000908259 OXIGENE INC OXGN 0001403961 Schwieterman William D C/O OXIGENE, INC. 701 GATEWAY BLVD., SUITE 210 SOUTH SAN FRANCISCO CA 94080 1 1 0 0 President and CEO Employee Stock Option (Right to Buy) 0.7277 2016-03-21 4 A 0 525000 0.00 A 2026-03-21 Common Stock 525000 525000 D Dr. Schwieterman was awarded options to purchase OXiGENE, Inc. common stock, $0.01 par value per share (the "Stock Options"), pursuant to the OXiGENE, Inc. 2015 Equity Incentive Plan in connection with his service as President and Chief Executive Officer. 25% of the Stock Options will vest on the first anniversary of the date of grant, and the remainder will vest in 36 substantially equal monthly installments beginning one year and one month after the grant date. /s/ Megan N. Gates, attorney-in-fact 2016-03-23